Bloomin' Brands

Bloomin' Brands provides a high-level disclosure of its key purchased animal proteins in its annual report and on its company website. The company reports that beef represents the majority of its purchased protein and lists its other major proteins as seafood, poultry, and dairy. The company does not specify what is meant by poultry, but it is assumed to represent mostly broilers. Bloomin' Brand also purchases a certain amount of pork and eggs as it has disclosed welfare commitments for these proteins on its company website: it published an Animal Welfare commitment to purchase 90% of its pork raised in group housing once pregnant by 2029 and to ensure that eggs procured globally are 100% cage-free by 2030. Although the company states that beef is its most purchased protein, it is unclear how material the company's other purchased proteins are.

Bloomin' Brands disclosed that it is committed to the responsible use of antibiotics on its company website and that its antibiotic requirements are aligned with guidelines outlined by organisations and government agencies such as the World Health Organization and World Organization for Animal Health. The company also reports that it requires its suppliers to follow FDA guidelines related to the use of antibiotics. While it is positive to see Bloomin' Brands report that it is committed to the responsible use of antibiotics, FAIRR does not consider the company to have a meaningful antibiotics policy in place as there is no evidence that the company has an antibiotic policy that bans or restricts the use of medically important antibiotics (MIA), as defined by the WHO, beyond FDA regulations.

There is no relevant disclosure for this KPI as Bloomin' Brands does not publicly disclose an antibiotic policy.

There is no relevant disclosure for this KPI as Bloomin' Brands does not disclose any evidence that it is tracking antibiotic use within its supply chain.

There is no relevant disclosure for this KPI as Bloomin' Brands does not disclose any evidence of auditing antibiotic use in its supply chain.

There is no relevant disclosure for this KPI as Bloomin' Brands does not disclose how it manages non-compliance of antibiotic use in its supply chain.

There is no relevant disclosure for this KPI as Bloomin' Brands has not publicly disclosed a target to reduce its antibiotic use within its supply chain.

There is no relevant disclosure for this KPI as Bloomin' Brands has not publicly disclosed a target to reduce its antibiotic use within its supply chain.

There is no relevant disclosure for this KPI as Bloomin’ Brands has not publicly disclosed a target to reduce its antibiotic use within its supply chain.

Bloomin' Brands is inactive and did not respond to the collaborative engagements formal letter sent in July.